Purpose: To present a Supera stent fracture following treatment of popliteal artery stenosis. Case Report: A 60-year-old man previously treated with angioplasty/stenting of a popliteal artery lesion with a Supera stent presented at 8 months with in-stent occlusion that proved to be secondary to stent fracture. Conclusion: Supera interwoven nitinol stents, despite having higher radial force and conformability than classic tube stents, are not free from fracture. Moreover, due to their peculiar structure, a break in these stents results in complete loss of integrity and consequent device collapse, thus jeopardizing endovascular recanalization and relining.
DearingDDPatelKRCompoginisJM. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg. 2007;50:542–547.
2.
NikanorovASchillingerMZhaoH. Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries. EuroIntervention. 2013;9:730–737.
3.
GoltzJPRitterCOKellersmannR. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19450–456.
4.
ScheinertDWernerMScheinertS. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent. JACC Cardiovasc Interv. 2013;6:65–71.
5.
ParkJYJeonYSChoSG. Stent fractures after superficial femoral artery stenting. J Korean Surg Soc. 2012;83:183–186.
6.
JaffMDakeMPompaJ. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc Interv. 2007;70:460–462.
7.
RastanAKrankenbergHBaumgartnerI. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial. J Endovasc Ther. 2015;22:22–27.
8.
WernerMPaetzoldABanning-EichenseerU. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent : midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2016;10:861–868.
9.
MyintMSchoutenOBourkeV. A real-world experience with the Supera interwoven nitinol stent in femoropopliteal arteries: midterm patency results and failure analysis. J Endovasc Ther. 2016;23:433–441.
10.
GarciaLJaffMRMetzgerC. Wire-interwoven nitinol stent outcome in the superficial twelve-month results of the SUPERB trial. Circ Cardiovasc Interv. 2015;8:e000937.
